| Oxidative stress from DGAT1 oncoprotein inhibition in melanoma suppresses tumor growth when ROS defenses are also breached DJ Wilcock, AP Badrock, CW Wong, R Owen, M Guerin, AD Southam, ... Cell reports 39 (12), 2022 | 22 | 2022 |
| PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models CW Wong, C Evangelou, KN Sefton, R Leshem, W Zhang, V Gopalan, ... Nature Communications 14 (1), 5983, 2023 | 7 | 2023 |
| The role of IFN-γ-signalling in response to immune checkpoint blockade therapy CW Wong, YY Huang, A Hurlstone Essays in Biochemistry 67 (6), 991-1002, 2023 | 2 | 2023 |
| PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven adaptive resistance CW Wong, C Evangelou, KN Sefton, R Leshem, K Sergiou, MLF Carro, ... bioRxiv, 2022.11. 18.517143, 2022 | 1 | 2022 |
| NRF2-mediated persistent adaptation of oesophageal adenocarcinoma cells to HER2 inhibition C Tournier, W Zhang, S Chattrakarn, CW Wong, S Li, K Kan, H Liu, W GU, ... | | 2024 |
| Abstract LB233: Single-cell transcriptional analysis of embryonic melanoblasts pinpoints embryonic cell states that underlie targeted therapy and immune checkpoint blockade … V Gopalan, CW Wong, CP Day, E Perez-Guijarro, MP Lee, Y Jiang, ... Cancer Research 84 (7_Supplement), LB233-LB233, 2024 | | 2024 |
| The development of CAR T cell therapeutics targeting tumor specific CD146 E Uzuner, H Mole, CW Wong, MLF Carro, R Leshem, K Sefton, H Tovey, ... Cancer Research 84 (6_Supplement), 4021-4021, 2024 | | 2024 |
| Abstract 625: PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven adaptive resistance CW Wong, C Evangelou, KN Sefton, R Leshem, K Sergiou, MLF Carro, ... AACR Annual Meeting 2023 83 (7_Supplement), 625, 2023 | | 2023 |
